ST-segment elevation resolution in lead aVR: a strong predictor of adverse outcomes in patients with non-ST-segment

Masami Kosuge1, Toshiaki Ebina, Kiyoshi Hibi

  • 1The Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.

Insights

ST-segment elevation in lead aVR without resolution in non-ST-segment elevation acute coronary syndromes (NSTE-ACS) patients predicts adverse outcomes. This finding highlights aVR ST elevation resolution as a crucial prognostic indicator in NSTE-ACS.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Diagnostic Electrocardiography

Background:

  • The prognostic significance of ST-segment elevation resolution in lead aVR for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) remains incompletely understood.
  • Lead aVR electrocardiogram (ECG) findings are increasingly recognized for their role in assessing acute coronary syndromes.

Purpose of the Study:

  • To investigate the impact of ST-segment elevation resolution in lead aVR on clinical outcomes in patients diagnosed with NSTE-ACS.
  • To determine if ST-segment elevation in lead aVR without subsequent resolution is an independent predictor of adverse events.

Main Methods:

  • Electrocardiograms (ECGs) were analyzed on admission and at 6 hours in 367 NSTE-ACS patients.
  • ST-segment elevation >or=0.5 mm in lead aVR was considered significant (ST upward arrowaVR).
  • ST resolution was defined as >50% reduction in ST elevation in lead aVR from admission to 6 hours.

Main Results:

  • 92 patients presented with ST upward arrowaVR; 50 achieved ST resolution.
  • ST upward arrowaVR without resolution was linked to older age, greater ST depression in other leads, elevated troponin T, and more extensive coronary artery disease (left main and/or 3-vessel).
  • Patients with ST upward arrowaVR without resolution had significantly higher rates of 30-day adverse events, including death, reinfarction, or urgent revascularization (HR 5.62, p=0.018).

Conclusions:

  • ST upward arrowaVR without ST resolution is a potent independent predictor of 30-day adverse outcomes in NSTE-ACS patients.
  • The absence of ST resolution in lead aVR correlates with the extent and severity of coronary artery disease.
  • Monitoring ST-segment resolution in lead aVR offers valuable prognostic information for NSTE-ACS management.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...